Insider · CIK 0001454240

Feeney John Joseph

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001454240

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2012-02-16	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+7,500 sh	—	—	15,000
2012-02-16	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+4,687 sh	—	—	19,687
2012-02-16	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−4,760 sh	$4.65	−$22.2K	14,927
2012-02-16	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−7,500 sh	—	—	15,000
2012-02-16	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−4,687 sh	—	—	14,063
2012-02-16	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+7,500 sh	—	—	12,015
2012-02-16	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+4,687 sh	—	—	16,702
2012-02-16	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−4,760 sh	$4.65	−$22.2K	11,942
2011-12-06	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+56.3K sh	—	—	56,250
2011-12-06	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitsA Award	SVP & Chief Medical Officer	AAward	+18.8K sh	—	—	18,750
2011-02-18	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+7,500 sh	—	—	7,500
2011-02-18	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−2,985 sh	$7.25	−$21.6K	4,515
2011-02-18	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−7,500 sh	—	—	22,500
2010-12-16	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+56.3K sh	—	—	56,250
2010-12-16	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitsA Award	SVP & Chief Medical Officer	AAward	+18.8K sh	—	—	18,750
2010-02-19	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−20K sh	$10.56	−$211K	0
2010-02-18	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+20K sh	—	—	20,000
2010-02-18	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−20K sh	—	—	0
2010-01-01	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitsA Award	SVP & Chief Medical Officer	AAward	+30K sh	—	—	30,000
2009-12-17	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	SVP & Chief Medical Officer	AAward	+70K sh	—	—	70,000
2009-11-06	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+9,583 sh	$8.73	+$83.7K	9,583
2009-11-06	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+572 sh	$5.76	+$3,294.72	10,155
2009-11-06	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+4,062 sh	$1.02	+$4,143.24	14,217
2009-11-06	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−14.2K sh	$10.33	−$147K	0
2009-11-06	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−9,583 sh	—	—	10,417
2009-11-06	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−572 sh	—	—	678
2009-11-06	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−4,062 sh	—	—	10,938
2009-05-22	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+95K sh	—	—	95,000
2009-05-18	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−6,562 sh	$12.00	−$78.7K	0
2009-05-13	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−3,000 sh	$12.00	−$36K	9,562
2009-05-13	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−1,100 sh	$12.19	−$13.4K	8,462
2009-05-13	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−500 sh	$12.20	−$6,100	7,962
2009-05-13	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−100 sh	$12.21	−$1,221	7,862
2009-05-13	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−100 sh	$12.22	−$1,222	7,762
2009-05-13	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−700 sh	$12.23	−$8,561	7,062
2009-05-13	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−100 sh	$12.24	−$1,224	6,962
2009-05-13	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−400 sh	$12.25	−$4,900	6,562
2009-05-12	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−7,438 sh	$10.11	−$75.2K	12,562
2009-05-11	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+20K sh	—	—	25,000
2009-05-11	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−5,000 sh	$9.14	−$45.7K	20,000
2009-05-11	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−20K sh	—	—	0
2009-05-06	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitsA Award	SVP & Chief Medical Officer	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Jul 204/A
Feeney John Joseph0001209191-12-038757
SEC(opens sec.gov)
Feb 214
Feeney John Joseph0001209191-12-011829
SEC(opens sec.gov)
Feb 135
Feeney John Joseph0001209191-12-009594
SEC(opens sec.gov)
Dec 84
Feeney John Joseph0001209191-11-060311
SEC(opens sec.gov)
Dec 174
Feeney John Joseph0001209191-10-061439
SEC(opens sec.gov)
Feb 234
Feeney John Joseph0001209191-10-011240
SEC(opens sec.gov)
Feb 194
Feeney John Joseph0001209191-10-010686
SEC(opens sec.gov)
Jan 54
Feeney John Joseph0001209191-10-000726
SEC(opens sec.gov)
Dec 184
Feeney John Joseph0001209191-09-057986
SEC(opens sec.gov)

Companies

Vanda Pharmaceuticals Inc.SVP & Chief Medical OfficerVNDA

Address

9605 MEDICAL CENTER DRIVE SUITE 300

ROCKVILLE, MD, 20850